Evidence map›Paper›PMID 24231355›Full record

ArticleThe Journal of clinical investigation2013

Topical hypochlorite ameliorates NF-κB-mediated skin diseases in mice.

Thomas H Leung, Lillian F Zhang, Jing Wang, Shoucheng Ning, Susan J Knox, Seung K Kim

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 102 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Model-Based Meta-Analysis to OptimizeJID innovations : skin science from molecules to population health · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Thomas H Leung
Lillian F Zhang
Jing Wang
Shoucheng Ning
Susan J Knox
Seung K Kim
Howard Hughes Medical Institute · US

Funding

Diabetes, Endocrinology and Metabolism Training GrantT32DK007217 · NIDDK · STANFORD UNIVERSITY · PI Justin Pierce Annes, David Matthew Maahs · 1987 to 2026
$7.2M
Howard Hughes Medical InstituteNIDDK NIH HHS DK007217-38NIDDK NIH HHS T32 DK007217
6 · The paper itself

Abstract

Nuclear factor-κB (NF-κB) regulates cellular responses to inflammation and aging, and alterations in NF-κB signaling underlie the pathogenesis of multiple human diseases. Effective clinical therapeutics targeting this pathway remain unavailable. In primary human keratinocytes, we found that hypochlorite (HOCl) reversibly inhibited the expression of CCL2 and SOD2, two NF-κB-dependent genes. In cultured cells, HOCl inhibited the activity of inhibitor of NF-κB kinase (IKK), a key regulator of NF-κB activation, by oxidizing cysteine residues Cys114 and Cys115. In NF-κB reporter mice, topical HOCl reduced LPS-induced NF-κB signaling in skin. We further evaluated topical HOCl use in two mouse models of NF-κB-driven epidermal disease. For mice with acute radiation dermatitis, topical HOCl inhibited the expression of NF-κB-dependent genes, decreased disease severity, and prevented skin ulceration. In aged mice, topical HOCl attenuated age-dependent production of p16INK4a and expression of the DNA repair gene Rad50. Additionally, skin of aged HOCl-treated mice acquired enhanced epidermal thickness and proliferation, comparable to skin in juvenile animals. These data suggest that topical HOCl reduces NF-κB-mediated epidermal pathology in radiation dermatitis and skin aging through IKK modulation and motivate the exploration of HOCl use for clinical aims.

Indexed as

Acid Anhydride HydrolasesAdministration, CutaneousAmino Acid SubstitutionAnimalsATP-Binding Cassette TransportersCells, CulturedChemokine CCL2Cyclin-Dependent Kinase Inhibitor p16CysteineDNA-Binding ProteinsDNA RepairDrug Evaluation, PreclinicalFemaleGene Expression RegulationGenes, ReporterHumansAcid Anhydride HydrolasesATP-Binding Cassette TransportersCCL2 protein, humanCdkn2a protein, mouseChemokine CCL2Cyclin-Dependent Kinase Inhibitor p16CysteineDNA-Binding ProteinsHypochlorous AcidI-kappa B KinaseNF-kappa BOxidantsRad50 protein, mouseSuperoxide DismutaseSuperoxide Dismutase 2Tumor Necrosis Factor-alpha

Identifiers

PMID24231355
PMCPMC3859383
OpenAlexW2147976168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.